Skip to main content
. Author manuscript; available in PMC: 2022 Apr 5.
Published in final edited form as: Drug Saf. 2018 Jan;41(1):87–94. doi: 10.1007/s40264-017-0591-5

Table 2.

Data capture of women and infants of exposed mothers in pregnancy exposure registries

Exposure No. of registries Achieved follow-up, % [median (IQR)] Achieved and ongoing follow-up, % [median (IQR)]

Womena 24 83.9 (72.5–94.5) 94.1 (75.7–97.3)
Infantsb
 Up to 4 weeks post-birth 4 89.9 (81.1–97.8) 92.1 (84.5–97.8)
 1–5 months 4 75.0 (72.0–82.1) 77.4 (75.2–82.6)
 >6 months 11 57.1 (35.0–71.6) 83.0 (67.7–92.6)

IQR interquartile range

a

Follow-up of exposed women was only reported for pregnancy exposure registries enrolling ≥10 pregnancies

b

Follow-up of infants of exposed mothers was only reported for pregnancy exposure registries enrolling ≥10 infants